Hyperandrogenism Protects Against High Blood Pressure by Nongenomic Mechanisms and Obesity Causes Hypertension in Females with Polycystic Ovary Syndrome

Androgens and Non-Genomic vascular responses in hypertension

(2022) Mercedes Perusquía   BIOCHEMICAL PHARMACOLOGY

The anti-androgenic effect of quercetin on hyperandrogenism and ovarian dysfunction induced in a dehydroepiandrosterone rat model of polycystic ovary syndrome

(2021) Asmaa A. Mahmoud et al.   STEROIDS

Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression

(2020) Mina Amiri et al.   Reproductive Biology and Endocrinology

TEMPORARY REMOVAL: Androgens and Blood Pressure Control: Sex Differences and Mechanisms

(2019) Jane F. Reckelhoff   MAYO CLINIC PROCEEDINGS

Vascular mechanisms of testosterone: The non-genomic point of view

(2019) Margarida Lorigo et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Vascular Pathways of Testosterone: Clinical Implications

(2019) Margarida Lorigo et al.   Journal of Cardiovascular Translational Research

Antihypertensive responses of vasoactive androgens in an in vivo experimental model of preeclampsia

(2018) Mercedes Perusquía et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Antihypertensive effects of androgens in conscious, spontaneously hypertensive rats

(2017) Mercedes Perusquía et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens

(2017) Licy L. Yanes Cardozo et al.   PHYSIOLOGY

Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review

(2017) Larissa Paixão et al.   Reproductive Biology and Endocrinology

Systemic hypotensive effects of testosterone are androgen structure-specific and neuronal nitric oxide synthase-dependent

(2015) Mercedes Perusquía et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Hypertension in Reproductive-Aged Women With Polycystic Ovary Syndrome and Association With Obesity

(2014) Anju E. Joham et al.   AMERICAN JOURNAL OF HYPERTENSION

Cryptotanshinone Reverses Reproductive and Metabolic Disturbances in PCOS Model Rats via Regulating the Expression of CYP17 and AR

(2014) Jin Yu et al.   Evidence-based Complementary and Alternative Medicine

Oriental Medicine Kyung-Ok-Ko Prevents and Alleviates Dehydroepiandrosterone-Induced Polycystic Ovarian Syndrome in Rats

(2014) Minhee Jang et al.   PLoS One

Testosterone: a vascular hormone in health and disease

(2013) Daniel M Kelly et al.   JOURNAL OF ENDOCRINOLOGY

Rodent Models for Human Polycystic Ovary Syndrome1

(2012) Kirsty A. Walters et al.   BIOLOGY OF REPRODUCTION

Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up

(2011) Miriam Hudecova et al.   FERTILITY AND STERILITY

Cardiovascular-Renal and Metabolic Characterization of a Rat Model of Polycystic Ovary Syndrome

(2011) Licy L. Yanes et al.   Gender Medicine

Do androgens play a beneficial role in the regulation of vascular tone? Nongenomic vascular effects of testosterone metabolites

(2010) Mercedes Perusquía et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Reduced total testosterone concentrations in young healthy South Asian men are partly explained by increased insulin resistance but not by altered adiposity.

(2010) Mousumi Biswas et al.   CLINICAL ENDOCRINOLOGY

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

(2008) Ricardo Azziz et al.   FERTILITY AND STERILITY